Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 3
1953 1
1964 1
1969 2
1970 4
1971 6
1972 1
1973 3
1974 3
1975 1
1976 2
1977 2
1978 10
1979 10
1980 4
1981 4
1982 2
1983 5
1984 3
1985 6
1986 5
1987 6
1988 5
1989 1
1990 6
1991 2
1992 1
1993 1
1994 8
1995 6
1996 7
1997 4
1998 6
1999 6
2000 8
2001 14
2002 5
2003 6
2004 10
2005 13
2006 14
2007 10
2008 9
2009 7
2010 4
2011 12
2012 11
2013 7
2014 8
2015 9
2016 18
2017 26
2018 23
2019 28
2020 19
2021 16
2022 14
2023 13
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

390 results

Results by year

Filters applied: . Clear all
Page 1
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer.
Kamoun A, de Reyniès A, Allory Y, Sjödahl G, Robertson AG, Seiler R, Hoadley KA, Groeneveld CS, Al-Ahmadie H, Choi W, Castro MAA, Fontugne J, Eriksson P, Mo Q, Kardos J, Zlotta A, Hartmann A, Dinney CP, Bellmunt J, Powles T, Malats N, Chan KS, Kim WY, McConkey DJ, Black PC, Dyrskjøt L, Höglund M, Lerner SP, Real FX, Radvanyi F; Bladder Cancer Molecular Taxonomy Group. Kamoun A, et al. Among authors: seiler r. Eur Urol. 2020 Apr;77(4):420-433. doi: 10.1016/j.eururo.2019.09.006. Epub 2019 Sep 26. Eur Urol. 2020. PMID: 31563503 Free PMC article.
Bladder cancer organoids as a functional system to model different disease stages and therapy response.
Minoli M, Cantore T, Hanhart D, Kiener M, Fedrizzi T, La Manna F, Karkampouna S, Chouvardas P, Genitsch V, Rodriguez-Calero A, Compérat E, Klima I, Gasperini P, Kiss B, Seiler R, Demichelis F, Thalmann GN, Kruithof-de Julio M. Minoli M, et al. Among authors: seiler r. Nat Commun. 2023 Apr 18;14(1):2214. doi: 10.1038/s41467-023-37696-2. Nat Commun. 2023. PMID: 37072390 Free PMC article.
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy.
Seiler R, Ashab HAD, Erho N, van Rhijn BWG, Winters B, Douglas J, Van Kessel KE, Fransen van de Putte EE, Sommerlad M, Wang NQ, Choeurng V, Gibb EA, Palmer-Aronsten B, Lam LL, Buerki C, Davicioni E, Sjödahl G, Kardos J, Hoadley KA, Lerner SP, McConkey DJ, Choi W, Kim WY, Kiss B, Thalmann GN, Todenhöfer T, Crabb SJ, North S, Zwarthoff EC, Boormans JL, Wright J, Dall'Era M, van der Heijden MS, Black PC. Seiler R, et al. Eur Urol. 2017 Oct;72(4):544-554. doi: 10.1016/j.eururo.2017.03.030. Epub 2017 Apr 5. Eur Urol. 2017. PMID: 28390739
Melioidosis, Singapore, 2003-2014.
Pang L, Harris PNA, Seiler RL, Ooi PL, Cutter J, Goh KT, Cook AR, Fisher D, Chai LYA. Pang L, et al. Among authors: seiler rl. Emerg Infect Dis. 2018 Jan;24(1):140-3. doi: 10.3201/eid2401.161449. Emerg Infect Dis. 2018. PMID: 29260679 Free PMC article.
Genomic Subtyping in Bladder Cancer.
Jalanko T, de Jong JJ, Gibb EA, Seiler R, Black PC. Jalanko T, et al. Among authors: seiler r. Curr Urol Rep. 2020 Mar 13;21(2):9. doi: 10.1007/s11934-020-0960-y. Curr Urol Rep. 2020. PMID: 32166460 Review.
Swiss germ-cell cancer consensus recommendations.
Beyer J, Berthold D, Bode PK, Cathomas R, Fankhauser CD, Fischer S, Gillessen S, Gross T, Hermanns T, Honecker F, Lorch A, Omlin A, Papachristofilou A, Roth B, Rothermundt C, Seiler R, Spahn M, Stenner F, Bührer E. Beyer J, et al. Among authors: seiler r. Swiss Med Wkly. 2021 Aug 23;151(33-34). doi: 10.4414/SMW.2021.w30023. Swiss Med Wkly. 2021. PMID: 34495606 Free article. Review.
[Molecular tumor board-urothelial cancer].
Hupe MC, Gakis G, Seiler R. Hupe MC, et al. Among authors: seiler r. Urologe A. 2019 Jul;58(7):760-767. doi: 10.1007/s00120-019-0967-5. Urologe A. 2019. PMID: 31172245 Free article. Review. German.
Bladder preservation after neoadjuvant therapy - 2021 IBCN updates part 1.
Hensley PJ, Seiler R, Herr H, Mouw KW, Iyer G, Dyrskjøt L, Nawroth R, Goebell P, Schmitz-Drager B, Todenhofer T, Black PC, Kamat AM, Williams SB. Hensley PJ, et al. Among authors: seiler r. Urol Oncol. 2023 Jul;41(7):307-312. doi: 10.1016/j.urolonc.2023.01.001. Epub 2023 Jan 25. Urol Oncol. 2023. PMID: 36702704 Review.
Unravelling disparate roles of NOTCH in bladder cancer.
Goriki A, Seiler R, Wyatt AW, Contreras-Sanz A, Bhat A, Matsubara A, Hayashi T, Black PC. Goriki A, et al. Among authors: seiler r. Nat Rev Urol. 2018 Jun;15(6):345-357. doi: 10.1038/s41585-018-0005-1. Nat Rev Urol. 2018. PMID: 29643502 Review.
Editorial: Cutting edge basic and clinical bladder cancer research - the IBCN updates.
Goebell PJ, Kamat AM, Black PC, Dyrskjøt L, Nawroth R, Seiler R, Todenhöfer T, Williams SB, Schmitz-Dräger BJ. Goebell PJ, et al. Among authors: seiler r. Urol Oncol. 2023 Jul;41(7):313-317. doi: 10.1016/j.urolonc.2022.12.013. Epub 2023 Jan 13. Urol Oncol. 2023. PMID: 36641302 Review. No abstract available.
390 results